For example, genetically increasing mTOR signaling can upregulate tau level and promote tau phosphorylation, but reducing mTOR signaling with rapamycin can ameliorate tau pathology and rescue motor deficits in a mouse model of tauopathy [74,75]. The gene discussed is MAPT; the disease is tauopathy.